Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series
Authors:
- Nicolas AnselminoNANicolas Anselmino
- Estefania LabancaELEstefania Labanca
- Peter D.A. ShepherdPSPeter D.A. Shepherd
- Jiabin DongJDJiabin Dong
- Jun YangJYJun Yang
- Xiaofei SongXSXiaofei Song
- Subhiksha NandakumarSNSubhiksha Nandakumar
- Ritika KundraRKRitika Kundra
- Cindy J. LeeCLCindy J. Lee
- Nikolaus SchultzNSNikolaus Schultz
- Jianhua ZhangJZJianhua Zhang
- John C. AraujoJAJohn C. Araujo
Open Access
- 15 March 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 30 (10) , 2272-2285
Abstract
Purpose: Develop and deploy a robust discovery platform that encompasses heterogeneity, clinical annotation, and molecular characterization and overcomes the limited availability of prostate cancer models. This initiative builds on the rich MD Anderson (MDA) prostate cancer (PCa) patient-derived xenograft (PDX) resource to complement existing publicly available databases by addressing gaps in clinically annotated models reflecting the heterogeneity of potentially lethal and lethal prostate cancer. Experimental Design: We performed whole-genome, targeted, and RNA sequencing in representative samples of the same tumor from 44 PDXs derived from 38 patients linked to donor tumor metadata and corresponding organoids. The cohort includes models derived from different morphologic groups, disease states, and involved organ sites (including circulating tumor cells), as well as paired samples representing heterogeneity or stages before and after therapy. Results: The cohort recapitulates clinically reported alterations in prostate cancer genes, providing a data resource for clinical and molecular interrogation of suitable experimental models. Paired samples displayed conserved molecular alteration profiles, suggesting the relevance of other regulatory mechanisms (e.g., epigenomic) influenced by the microenvironment and/or treatment. Transcriptomically, models were grouped on the basis of morphologic classification. DNA damage response–associated mechanisms emerged as differentially regulated between adenocarcinoma and neuroendocrine prostate cancer in a cross-interrogation of PDX/patient datasets. Conclusions: We addressed the gap in clinically relevant prostate cancer models through comprehensive molecular characterization of MDA PCa PDXs, providing a discovery platform that integrates with patient data and benchmarked to therapeutically relevant consensus clinical groupings. This unique resource supports robust hypothesis generation and testing from basic, translational, and clinical perspectives.Keywords
All Related Versions
Funding Information
- Prostate Cancer Foundation
- National Cancer Institute (P50 CA140388)
- National Cancer Institute (U01 CA224044)
- National Cancer Institute (P50CA092629)
- National Cancer Institute (P30CA008748)
This publication has 47 references indexed in Scilit:
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNature Genetics, 2012
- The mutational landscape of lethal castration-resistant prostate cancerNature, 2012
- Roles of inositol phosphates and inositol pyrophosphates in development, cell signaling and nuclear processesAdvances in Enzyme Regulation, 2010
- ETS gene fusions in prostate cancerNature Reviews Urology, 2009
- SLC45A3-ELK4 Is a Novel and Frequent Erythroblast Transformation–Specific Fusion Transcript in Prostate CancerCancer Research, 2009
- Transcriptome sequencing to detect gene fusions in cancerNature, 2009
- Androgen receptor–negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanismsJournal of Clinical Investigation, 2008
- Heterogeneity and clinical significance of ETV1 translocations in human prostate cancerBritish Journal of Cancer, 2008
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007
- Infrequent RAS oncogene mutations in human prostate cancerThe Prostate, 1992